Comparison of Efficacy Compressive Stockings with Heparin in Prevention of Deep Vein Thrombosis in Stroke Patients

Authors

Nastaran Majdinasab1,*, Gholamreza Shamsaei1, Asal Faraji1, Reza Haj-Manoochehri1, Vahid Abbasi1
1Department of Neurology, Ahwaz Jundishapur University of Medical Sciences, Ahwaz, Iran
*Corresponding Author: Department of Neurology, Ahwaz Jundishapur University of Medical Sciences, Ahwaz, Iran Email: [email protected]

Zahedan Journal of Research in Medical Sciences:Vol. 15, issue 4; e93036
Published online:Nov 05, 2012
Article type:Brief Report
Received:Feb 07, 2011
Accepted:Apr 23, 2011
How to Cite:Majdinasab N, Shamsaei G, Faraji A, Haj-Manoochehri R, Abbasi V. Comparison of Efficacy Compressive Stockings with Heparin in Prevention of Deep Vein Thrombosis in Stroke Patients. Zahedan J Res Med Sci. 2013;15(4):e93036. doi:

Abstract

Background : The present study is carried out to make a comparison between two pharmacological (heparin) and physical (compression stockings) in the prevention of deep vein thrombosis in lower limb of the patients suffered from acute stroke.
Materials and Methods : In this investigation as a clinical trial, the effectiveness of the above methods on 100 patients with the stroke was compared in two groups of 50 persons.
Results : Three patients in physical group and two patients in pharmacological group got deep vein thrombosis that showed no significant difference between two groups.
Conclusion : In spite of no significant relationship and due to less incurrence of thrombosis in heparin group, it is more reasonable to use pharmacological methods.

Fulltext

The full text of this article is available on the PDF file.

References

  • 1.
    The References of this article are available on the PDF file.

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

11
Apr
2022
Enoxaparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke

Enoxaparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke

Khanh Nguyen Duy,
Diem Thi Nguyen,
Minh Van Le,
Long Duy Le,
Huy Cong Tran,
Nhan Huu Kha
,et al.

Duy KN, Nguyen DT, Le MV, Le LD, Tran HC, et al. Enoxaparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke. J Adv Immunopharmacol. 2022;2(1):e122415. doi: https://doi.org/10.5812/tms-122415

24
Sep
2006

The influence of heparin on prevention of the deep vein thrombosis in patients who were under laparoscopic cholecystectomy operation

HamidReza Hemati,
Soheil Ghanad,
Mozhegan EftekharPor

Hemati H, Ghanad S, EftekharPor M. The influence of heparin on prevention of the deep vein thrombosis in patients who were under laparoscopic cholecystectomy operation. koomesh. 2006;7(3):e152105. doi:

31
Dec
2002

Comparison of the results of color doppler sonography and venography in deep vein thrombosis diagnosis

A Hekmatnia,
A Pourmoghaddas

Hekmatnia A, Pourmoghaddas A. Comparison of the results of color doppler sonography and venography in deep vein thrombosis diagnosis. J Inflamm Dis. 2024;6(3):e154890. doi:

25
Jun
2016

Pharmacomechanical Thrombolytic Treatment in Symptomatic Acute and Subacute Deep Vein Thrombosis

Ekin Ilkeli,
Oytun Saffet Kahyaoglu,
Selim Capci,
Ramazan Buyukkaya,
Nilay Aydin Oktay,
Aysegul Koc

Ilkeli E, Saffet Kahyaoglu O, Capci S, Buyukkaya R, Aydin Oktay N, et al. Pharmacomechanical Thrombolytic Treatment in Symptomatic Acute and Subacute Deep Vein Thrombosis. I J Radiol. 2017;14(1):e13467. doi: https://doi.org/10.5812/iranjradiol.30559

30
Sep
2009

Prevention of Deep Vein Thrombosis Associated with Temporary Transvenous Cardiac Pacemakers by Enoxaparin

Mohammad Javad Zibaeenezhad,
E Atabati,
K Aghasadeghi

Zibaeenezhad MJ, Atabati E, Aghasadeghi K. Prevention of Deep Vein Thrombosis Associated with Temporary Transvenous Cardiac Pacemakers by Enoxaparin. Int Cardiovasc Res J. 2009;3(3):e68037. doi:

More by these authors

Nastaran MajdinasabPubMedScholar
Gholamreza ShamsaeiPubMedScholar
Asal FarajiPubMedScholar
Reza Haj-ManoochehriPubMedScholar
Vahid AbbasiPubMedScholar
Share
Cited by
Metrics